“Pharmacy Care” OTC Category Considered By APhA Task Force
This article was originally published in The Tan Sheet
Executive Summary
A new category of "pharmacy care" drugs could broaden access to certain over-the-counter drugs, according to the American Pharmacists Association
You may also be interested in...
Mevacor “Pharmacy Care” Tactic Insufficient To Ensure Compliance – Panel
The American Pharmacists Association's proposed "pharmacy care" model fell short of convincing FDA advisory panelists to recommend OTC status for Mevacor Daily
Mevacor OTC opinions
American Pharmacists Association supports a "strong role" for pharmacists if an Rx-to-OTC switch of lovastatin 20 mg were to be approved, former APhA President Janet Engle says Jan. 14. An APhA task force developed the "pharmacy care OTC" category for drugs to treat chronic, asymptomatic conditions last fall (1"The Tan Sheet" Nov. 8, 2004, p. 10). J&J/Merck says OTC Mevacor should be sold only in retail outlets with a pharmacy. FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 20-3 against the switch...
NDAC/Endocrinologic Drug Joint Panel Meeting Likely To Focus On Statins
A two-day joint meeting of the Nonprescription Drugs and Endocrinologic & Metabolic Drugs Advisory Committees is scheduled for Jan. 13-14, 2005